What to expect from metformin for PCOS-related anovulation

Anovulation means the ovary does not release an egg during a cycle. In PCOS, altered insulin signalling can contribute to hormone changes that interfere with follicle development and ovulation. Metformin improves insulin sensitivity, which may help the body’s hormone pattern become more favourable for ovulation. It is not an immediate ovulation trigger, and its effect differs between individuals.

The medicine is often introduced gradually to make nausea, loose stools, abdominal discomfort or reduced appetite easier to manage. Taking it with food may help. Your clinician may review cycles, ovulation signs, blood tests or fertility goals before deciding whether to continue, adjust or add another treatment.

Take metformin exactly as prescribed and do not double a missed dose unless your clinician tells you to. Tell the prescriber about kidney or liver problems, heavy alcohol use, pregnancy, breastfeeding and other medicines. Keep appointments for any recommended blood tests. If pregnancy is possible, ask whether to continue metformin and how ovulation or pregnancy monitoring should change.

Contact your clinician if digestive symptoms are persistent, prevent eating or drinking, or make you consider stopping treatment. Seek urgent help for marked weakness, breathing difficulty, severe abdominal symptoms, confusion or unusual sleepiness. These symptoms are uncommon but need prompt assessment rather than self-adjusting the dose.

Ask what improvement to look for, how dose increases will work, whether an extended-release form is suitable, and how ovulation will be checked. If conception is your goal, ask when to review the plan and which fertility treatments could be considered if ovulation remains absent.